OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 10, 2026
$5,95
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,6652-Wochen-Tief
$6,5052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$358M
P/E (TTM)
-7.2
EPS (TTM)
$-0.83
Umsatz (TTM)
$32M
Ihre Abzeichen
52W-Spanne
$3–$6
Analystenbewertung
BUY
Kursziel
$12
P/E
-7.2
ROE
-601.8%
Nettogewinnmarge
-184.6%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
OBIO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$5.95
Marktkapitalisierung (MRQ)
$358M
P/E (TTM)
-7.2
EPS (TTM)
$-0.83
Umsatz (TTM)
$32M
ROE (TTM)
-601.8%
52W-Spanne
$3–$7
OBIO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$33M2022-12-31 → 2025-12-31
EPS$-1.112021-12-31 → 2025-12-31
Freier Cashflow$-49M2023-12-31 → 2025-12-31
Nettogewinnmarge-184.6%2023-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | OBIO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -7.25-Jahres-Durchschnitt ≈-104.2 | ≈-104.2 | · | · | |
| P/S (TTM) | 11.25-Jahres-Durchschnitt ≈49.0 | ≈49.0 | 5.5 | Überbewertet | |
| K/B (MRQ) | 18.55-Jahres-Durchschnitt ≈-0.8 | ≈-0.8 | 4.6 | Überbewertet | |
| Kurs / FCF (TTM) | -6.15-Jahres-Durchschnitt ≈-5.0 | ≈-5.0 | · | · | |
| Kurs / Cashflow (TTM) | -6.15-Jahres-Durchschnitt ≈-41.6 | ≈-41.6 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 6.35-Jahres-Durchschnitt ≈3.7 | ≈3.7 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | OBIO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -181.4%5-Jahres-Durchschnitt ≈-1486.1% | ≈-1486.1% | -58.4% | Schwach | |
| EBITDA-Marge (TTM) | -180.3%5-Jahres-Durchschnitt ≈-1478.4% | ≈-1478.4% | -58.4% | Schwach | |
| Nettogewinnmarge (TTM) | -184.6%5-Jahres-Durchschnitt ≈-1416.8% | ≈-1416.8% | -57.3% | Schwach | |
| ROA (TTM) | -74.5%5-Jahres-Durchschnitt ≈-36.1% | ≈-36.1% | -32.6% | Schwach | |
| ROE (TTM) | -601.8%5-Jahres-Durchschnitt ≈-83.3% | ≈-83.3% | -106.9% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | OBIO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 8.35-Jahres-Durchschnitt ≈5.9 | ≈5.9 | 4.9 | Starke Liquidität | |
| Quick Ratio (MRQ) | 8.25-Jahres-Durchschnitt ≈5.8 | ≈5.8 | 3.7 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | OBIO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 1169.2%5-Jahres-Durchschnitt ≈381.0% | ≈381.0% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 111.6% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | OBIO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.45-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.6 | Schwach | |
| Inventory Turnover (Lagerumschlag) | 0.85-Jahres-Durchschnitt ≈1.0 | ≈1.0 | 1.5 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 358.15-Jahres-Durchschnitt ≈138.0 | ≈138.0 | 6.6 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$389.3K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
18.1%
Nächster Bericht
Nov 09, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 18, 2026 | $-0.38 | $-0.40 | 5.0% |
| 31. März 2026 | Mai 18, 2026 | $-0.33 | $-0.44 | 24.9% |
| 31. Dezember 2025 | $-0.13 | $-0.39 | 66.3% | |
| 30. September 2025 | $-0.40 | $-0.44 | 9.8% | |
| 30. Juni 2025 | $-0.50 | $-0.51 | 2.7% | |
| 31. März 2025 | $-0.49 | $-0.49 | 0.12% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $33M | $3M | $3M | $4M | |
| Cost of Revenue | $190.0K | $204.0K | $186.0K | $211.0K | |
| R&D Expense | $58M | $43M | $34M | $22M | |
| SG&A Expense | $27M | $24M | $20M | $14M | |
| Operating Expenses | $85M | $67M | $54M | $36M | |
| Operating Income | $-52M | $-64M | $-52M | $-33M | |
| Interest Income | · | · | · | $345.1K | |
| Other Non-op | · | $-11.0K | · | · | |
| Income Tax | $0 | · | · | · | |
| Net Income | $-53M | $-61M | $-49M | $-34M | |
| EPS (Basic) | $-1.11 | $-1.66 | $-1.48 | $-2.24 | |
| EPS (Diluted) | $-1.11 | $-1.66 | $-1.48 | $-2.24 | |
| Shares (Basic) | 47,747,078 | 36,821,042 | 33,225,227 | 14,988,584 | |
| Shares (Diluted) | 47,747,078 | 36,821,042 | 33,225,227 | 14,988,584 | |
| EBITDA | $-51M | $-64M | $-51M | $-3M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $35M | $22M | $31M | $20M | |
| Short-term Investments | $72M | $45M | $57M | $64M | |
| Receivables | $95.0K | $92.0K | $99.0K | $96.0K | |
| Inventory | $310.0K | $173.0K | $146.0K | $276.0K | |
| Prepaid Expense | $994.0K | $2M | $1M | $533.0K | |
| Current Assets | $108M | $69M | $89M | $85M | |
| PP&E (Net) | $2M | $1M | $1M | $1M | |
| PP&E (Gross) | $3M | $3M | $2M | $2M | |
| Accum. Depreciation | $2M | $1M | $1M | $778.0K | |
| Total Assets | $115M | $76M | $95M | $96M | |
| Accounts Payable | $6M | $5M | $3M | $4M | |
| Accrued Liabilities | $10M | $6M | $5M | $5M | |
| Current Liabilities | $17M | $16M | $11M | $19M | |
| Capital Leases | $936.0K | $2M | $1M | $2M | |
| Deferred Tax | $393.0K | $561.0K | $508.0K | $637.0K | |
| Other Non-current Liabilities | $308.0K | $40.0K | · | $196.0K | |
| Total Liabilities | $51M | $43M | $27M | $43M | |
| Long-term Debt | $15M | $15M | · | · | |
| Common Stock | $6.0K | $4.0K | $4.0K | $2.0K | |
| Paid-in Capital | $416M | $343M | $317M | $252M | |
| Retained Earnings | $-363M | $-310M | $-249M | $-200M | |
| AOCI | $60.0K | $52.0K | $-10.0K | $-8.0K | |
| Stockholders' Equity | $54M | $33M | $68M | $53M | |
| Liabilities + Equity | $115M | $76M | $95M | $96M | |
| Shares Outstanding | 57,032,963 | 38,194,442 | 35,777,412 | 20,187,850 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $327.0K | $308.0K | $287.0K | $222.0K | |
| Stock-based Comp | $12M | $11M | $8M | $3M | |
| Other Non-cash | $-9M | $-457.0K | $-5M | · | |
| Operating Cash Flow | $-49M | $-51M | $-46M | $-29M | |
| CapEx | $489.0K | $289.0K | $78.0K | $591.0K | |
| Investing Cash Flow | $-27M | $13M | $11M | $-64M | |
| Net Debt Issued | · | · | $-11M | · | |
| Financing Cash Flow | $88M | $29M | $46M | $103M | |
| Net Change in Cash | $12M | $-8M | $11M | $10M | |
| Free Cash Flow | $-49M | $-51M | $-46M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -154.7% | -2437.5% | -1866.2% | · | |
| Net Margin | -157.4% | -2313.3% | -1779.7% | · | |
| EBITDA Margin | -153.8% | -2425.8% | -1855.8% | · | |
| ROA | -55.2% | -71.2% | -51.5% | -2.4% | |
| ROE | -195.7% | -154.2% | -66.5% | -10.0% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 6.4 | 4.3 | 8.0 | 0.2 | |
| Quick Ratio | 6.4 | 4.1 | 7.8 | 0.1 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.0 | 0.0 | · | |
| Inventory Turnover | 0.8 | 1.3 | 0.9 | · | |
| Receivables Turnover | 358.1 | 27.6 | 28.3 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $0.94 | $0.86 | $1.90 | $-1.56 | |
| Revenue / Share | $0.70 | $0.07 | $0.08 | · | |
| Cash Flow / Share | $-1.03 | $-1.37 | $-1.39 | $-0.10 | |
| Cash / Share | $0.61 | $0.58 | $0.85 | $0.04 | |
| EPS (TTM) | $-1.11 | $-1.66 | $-1.48 | $-2.24 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 1169.2% | -4.4% | -21.9% | · | |
| Revenue CAGR 3Y | 111.6% | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $33M | $3M | $3M | $4M | |
| Net Income TTM | $-53M | $-61M | $-49M | $-34M | |
| Market Cap | $237M | $153M | $327M | $44M | |
| P/E | -3.7 | -2.4 | -6.2 | -4.5 | |
| P/S | 7.1 | 57.9 | 118.4 | 12.6 | |
| P/B | 4.4 | 4.6 | 4.8 | -6.4 | |
| P / Tangible Book | 4.4 | 4.6 | 4.8 | 0.8 | |
| P / Cash Flow | -4.8 | -3.0 | -7.1 | -28.1 | |
| P / FCF | -4.8 | -3.0 | -7.1 | · | |
| Earnings Yield | -26.8% | -41.5% | -16.2% | -22.4% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88.0K | $110.0K | $31M | $861.0K | $836.0K | $868.0K | $253.0K | $987.0K | $778.0K | $620.0K | $262.0K | $419.0K | $915.0K | $1M | $1M | $1M | |
| Cost of Revenue | $25.0K | $32.0K | $51.0K | $49.0K | $46.0K | $44.0K | $58.0K | $68.0K | $44.0K | $34.0K | $47.0K | $41.0K | $54.0K | $44.0K | $53.0K | $56.0K | |
| R&D Expense | $17M | $16M | $17M | $14M | $14M | $13M | $11M | $12M | $11M | $9M | $9M | $9M | $8M | $8M | $8M | $6M | |
| SG&A Expense | $6M | $6M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $4M | $6M | $5M | $4M | $3M | $5M | |
| Operating Expenses | $22M | $22M | $24M | $21M | $20M | $20M | $17M | $17M | $18M | $15M | $13M | $15M | $14M | $13M | $11M | $11M | |
| Operating Income | $-22M | $-22M | $7M | $-20M | $-19M | $-19M | $-17M | $-16M | $-17M | $-14M | $-12M | $-15M | $-13M | $-12M | $-10M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | $351.0K | · | · | |
| Other Non-op | · | · | · | · | · | · | $0 | $0 | $0 | $-11.0K | · | · | · | · | · | · | |
| Net Income | $-24M | $-21M | $6M | $-21M | $-19M | $-19M | $-16M | $-15M | $-16M | $-13M | $-13M | $-13M | $-12M | $-11M | $-10M | $-10M | |
| EPS (Basic) | $-0.38 | $-0.33 | $0.28 | $-0.40 | $-0.50 | $-0.49 | $-0.42 | $-0.41 | $-0.45 | $-0.38 | $-0.35 | $-0.38 | $-0.35 | $-0.40 | $-0.34 | $-0.51 | |
| EPS (Diluted) | $-0.38 | $-0.33 | $0.28 | $-0.40 | $-0.50 | $-0.49 | $-0.42 | $-0.41 | $-0.45 | $-0.38 | $-0.35 | $-0.38 | $-0.35 | $-0.40 | $-0.34 | $-0.51 | |
| Shares (Basic) | 63,812,098 | 62,721,869 | · | 52,186,503 | 38,392,716 | 38,235,409 | · | 37,621,495 | 35,800,273 | 35,777,877 | · | 35,243,598 | 34,613,466 | 27,643,549 | · | 20,187,773 | |
| Shares (Diluted) | 63,812,098 | 62,721,869 | · | 52,186,503 | 38,392,716 | 38,235,409 | · | 37,621,495 | 35,800,273 | 35,777,877 | · | 35,243,598 | 34,613,466 | 27,643,549 | · | 20,187,773 | |
| EBITDA | $-22M | $-22M | · | $-20M | $-19M | $-19M | · | $-16M | $-17M | $-14M | · | $-15M | $-13M | $-11M | · | $-813.4K |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $28M | $35M | $42M | $19M | $18M | $22M | $26M | $24M | $23M | $31M | $19M | $16M | $19M | $20M | $735.2K | |
| Short-term Investments | $89M | $66M | $72M | $54M | $15M | $32M | $45M | $41M | $41M | $52M | $57M | $89M | $101M | $108M | $64M | · | |
| Receivables | $51.0K | $84.0K | $95.0K | $52.0K | $83.0K | $89.0K | $92.0K | $115.0K | $80.0K | $67.0K | $99.0K | $86.0K | $171.0K | $76.0K | $96.0K | · | |
| Inventory | $250.0K | $277.0K | $310.0K | $365.0K | $185.0K | $135.0K | $173.0K | $234.0K | $70.0K | $115.0K | $146.0K | $137.0K | $178.0K | $232.0K | $276.0K | · | |
| Prepaid Expense | $977.0K | $1M | $994.0K | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $533.0K | $137.3K | |
| Current Assets | $111M | $96M | $108M | $98M | $36M | $52M | $69M | $69M | $66M | $76M | $89M | $110M | $120M | $130M | $85M | $872.6K | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $993.0K | $921.0K | $849.0K | $778.0K | · | |
| Total Assets | $116M | $101M | $115M | $105M | $43M | $59M | $76M | $75M | $72M | $83M | $95M | $116M | $126M | $136M | $96M | $69M | |
| Accounts Payable | $6M | $6M | $6M | $8M | $5M | $6M | $5M | $5M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $281.6K | |
| Accrued Liabilities | $7M | $7M | $10M | $7M | $7M | $5M | $6M | $7M | $4M | $4M | $5M | $4M | $4M | $3M | $5M | $1M | |
| Current Liabilities | $13M | $14M | $17M | $21M | $17M | $15M | $16M | $16M | $15M | $10M | $11M | $21M | $12M | $12M | $19M | $1M | |
| Capital Leases | $520.0K | $730.0K | $936.0K | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | · | |
| Deferred Tax | · | · | $393.0K | · | · | · | $561.0K | · | · | · | $508.0K | · | · | · | $637.0K | · | |
| Other Non-current Liabilities | $397.0K | $367.0K | $308.0K | $248.0K | $189.0K | $99.0K | $40.0K | · | · | · | · | $266.0K | $213.0K | $249.0K | $196.0K | · | |
| Total Liabilities | $86M | $50M | $51M | $61M | $43M | $42M | $43M | $29M | $28M | $25M | $27M | $37M | $36M | $37M | $43M | $7M | |
| Long-term Debt | · | $15M | $15M | $15M | $15M | $15M | · | · | · | · | · | $10M | $10M | · | · | · | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $2.0K | $445 | |
| Paid-in Capital | $426M | $424M | $416M | $413M | $348M | $345M | $343M | $340M | $322M | $320M | $317M | $316M | $312M | $310M | $252M | · | |
| Retained Earnings | $-407M | $-383M | $-363M | $-369M | $-348M | $-329M | $-310M | $-294M | $-278M | $-262M | $-249M | $-236M | $-223M | $-211M | $-200M | $-6M | |
| AOCI | $-81.0K | $-40.0K | $60.0K | $45.0K | $16.0K | $37.0K | $52.0K | $98.0K | $-23.0K | $-8.0K | $-10.0K | $-77.0K | $-96.0K | $-35.0K | $-8.0K | · | |
| Stockholders' Equity | $19M | $41M | $54M | $44M | $295.0K | $17M | $33M | $46M | $44M | $57M | $68M | $80M | $89M | $100M | $53M | $-6M | |
| Liabilities + Equity | $116M | $101M | $115M | $105M | $43M | $59M | $76M | $75M | $72M | $83M | $95M | $116M | $126M | $136M | $96M | $69M | |
| Shares Outstanding | 60,105,049 | 58,630,715 | 57,032,963 | 56,464,731 | 38,643,553 | 38,312,512 | 38,194,442 | 37,942,905 | 35,824,571 | 35,784,997 | 35,777,412 | 35,743,972 | 35,743,007 | 31,741,147 | 20,187,850 | 4,450,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96.0K | $90.0K | $82.0K | $81.0K | $81.0K | $83.0K | $84.0K | $76.0K | $74.0K | $74.0K | $72.0K | $71.0K | $73.0K | $71.0K | $70.0K | $54.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $919.0K | $4M | $2M | $1M | $863.0K | $2M | |
| Other Non-cash | · | $-4M | · | · | · | $-909.0K | · | · | · | $-2M | · | · | · | $-5M | · | · | |
| Operating Cash Flow | $-19M | $-22M | $-2M | $-15M | $-16M | $-17M | $-14M | $-14M | $-10M | $-13M | $-11M | $-10M | $-10M | $-14M | $-9M | $-20M | |
| CapEx | $254.0K | $184.0K | $33.0K | $310.0K | $34.0K | $112.0K | $106.0K | $68.0K | $107.0K | $8.0K | $-3.0K | $19.0K | $27.0K | $35.0K | $54.0K | $224.0K | |
| Investing Cash Flow | $-23M | $10M | $-18M | $-39M | $16M | $13M | $-4M | $557.0K | $10M | $6M | $33M | $13M | $8M | $-44M | $-63M | $-224.0K | |
| Financing Cash Flow | $35M | $6M | $13M | $76M | $-428.0K | $-296.0K | $14M | $15M | $171.0K | $18.0K | $-11M | $4.0K | $86.0K | $57M | $-5M | $-2M | |
| Net Change in Cash | $-8M | $-6M | $-7M | $23M | $401.0K | $-4M | $-3M | $2M | $389.0K | $-7M | $11M | $3M | $-2M | $-1M | $-77M | $88M | |
| Free Cash Flow | · | $-22M | · | · | · | $-17M | · | · | · | $-13M | · | · | · | $-14M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -25404.5% | -20069.1% | · | -2359.2% | -2311.8% | -2179.8% | · | -1655.7% | -2167.0% | -2326.3% | · | -3466.3% | -1416.0% | -991.8% | · | · | |
| Net Margin | -26994.3% | -18810.0% | · | -2419.1% | -2316.2% | -2160.7% | · | -1562.9% | -2054.0% | -2171.5% | · | -3178.0% | -1316.5% | -939.9% | · | · | |
| EBITDA Margin | -25404.5% | -19987.3% | · | -2359.2% | -2311.8% | -2170.3% | · | -1655.7% | -2167.0% | -2314.3% | · | -3466.3% | -1416.0% | -985.7% | · | · | |
| ROA | -30.0% | -25.9% | · | -23.1% | -33.6% | -26.5% | · | -16.1% | -16.1% | -12.3% | · | -14.4% | -8.4% | -7.3% | · | -0.59% | |
| ROE | -242.2% | -71.3% | · | -46.3% | -87.2% | -50.7% | · | -24.5% | -23.9% | -17.2% | · | -36.2% | -28.6% | -22.9% | · | 13.8% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.3 | 7.0 | · | 4.7 | 2.1 | 3.4 | · | 4.2 | 4.6 | 7.3 | · | 5.1 | 10.1 | 10.8 | · | 0.6 | |
| Quick Ratio | 8.2 | 6.9 | · | 4.6 | 2.0 | 3.2 | · | 4.1 | 4.5 | 7.2 | · | 5.1 | 9.9 | 10.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | -32.9 | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.1 | 0.2 | · | 0.2 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.2 | · | 0.6 | 0.6 | 0.4 | · | · | |
| Receivables Turnover | 1.3 | 1.3 | · | 10.3 | 10.3 | 11.1 | · | 9.8 | 6.2 | 8.7 | · | 9.7 | 10.7 | 30.6 | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.32 | $0.70 | · | $0.77 | $0.01 | $0.44 | · | $1.22 | $1.23 | $1.60 | · | $2.23 | $2.50 | $3.14 | · | $-1.36 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.02 | $0.02 | $0.02 | · | $0.03 | $0.02 | $0.02 | · | $0.01 | $0.03 | $0.04 | · | · | |
| Cash Flow / Share | · | $-0.35 | · | · | · | $-0.43 | · | · | · | $-0.37 | · | · | · | $-0.52 | · | · | |
| Cash / Share | $0.34 | $0.48 | · | $0.74 | $0.49 | $0.48 | · | $0.67 | $0.66 | $0.65 | · | $0.53 | $0.46 | $0.59 | · | $0.17 | |
| EPS (TTM) | $-0.83 | $-0.95 | · | $-1.81 | $-1.82 | $-1.77 | · | $-1.59 | $-1.56 | $-1.46 | · | $-1.47 | $-1.60 | $-2.02 | · | $-1.91 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $32M | $33M | · | $3M | $3M | $3M | · | $3M | $2M | $2M | · | $4M | $4M | $4M | · | · | |
| Net Income TTM | $-59M | $-55M | · | $-75M | $-70M | $-66M | · | $-58M | $-56M | $-52M | · | $-46M | $-43M | $-39M | · | $-24M | |
| Market Cap | $259M | $249M | · | $140M | $104M | $164M | · | $195M | $292M | $189M | · | $312M | $250M | $621M | · | $44M | |
| P/E | -5.2 | -4.5 | · | -1.4 | -1.5 | -2.4 | · | -3.2 | -5.2 | -3.6 | · | -5.9 | -4.4 | -9.7 | · | -5.2 | |
| P/S | 8.1 | 7.6 | · | 49.7 | 35.2 | 56.8 | · | 73.7 | 140.4 | 85.1 | · | 86.6 | 57.6 | 162.1 | · | · | |
| P/B | 13.4 | 6.0 | · | 3.2 | 351.1 | 9.7 | · | 4.2 | 6.6 | 3.3 | · | 3.9 | 2.8 | 6.2 | · | -7.3 | |
| P / Tangible Book | 13.4 | 6.0 | · | 3.2 | 351.1 | 9.7 | · | 4.2 | 6.6 | 3.3 | · | 3.9 | 2.8 | 6.2 | · | · | |
| P / Cash Flow | · | -11.2 | · | · | · | -9.9 | · | · | · | -14.4 | · | · | · | -43.2 | · | · | |
| Earnings Yield | -19.2% | -22.4% | · | -73.0% | -67.9% | -41.4% | · | -30.9% | -19.1% | -27.7% | · | -16.9% | -22.9% | -10.3% | · | -19.3% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $33M | $3M | $3M | $4M | · |
| Betriebsgewinnmarge % | -154.7% | -2437.5% | -1866.2% | · | · |
| Nettoergebnis | $-53M | $-61M | $-49M | $-34M | $-378.8K |
| Verwässerte EPS | $-1.11 | $-1.66 | $-1.48 | $-2.24 | $-0.02 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 6.4 | 4.3 | 8.0 | 0.2 | 10.9 |
| Quick Ratio | 6.4 | 4.1 | 7.8 | 0.1 | 10.6 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-49M | $-51M | $-46M | · | · |
Institutionelle Eigentümer (13F) 86 Einreicher · $124.3M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
86
Gehaltener Wert
$124.3M
Neue Positionen
27
Geschlossene Positionen
13
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 27 (+8 vs. Vorquartal) | 13 (0 vs. Vorquartal) | 22 (-2 vs. Vorquartal) | 15 (+1 vs. Vorquartal) | +4.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $41.234.412 | 9.556.063 | 33,19% | Aktien |
| PERCEPTIVE ADVISORS LLC | $21.738.564 | 5.037.906 | 17,50% | Aktien |
| BlackRock, Inc. | $10.832.320 | 2.510.387 | 8,72% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.728.883 | 2.022.916 | 7,03% | Aktien |
| VANGUARD GROUP INC | $6.658.907 | 1.604.556 | 5,36% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $4.350.317 | 1.007.908 | 3,50% | Aktien |
| Alyeska Investment Group, L.P. | $4.315.000 | 1.000.000 | 3,47% | Aktien |
| Propel Bio Management, LLC | $3.869.265 | 896.701 | 3,11% | Aktien |
| STATE STREET CORP | $2.226.756 | 516.050 | 1,79% | Aktien |
| RICE HALL JAMES & ASSOCIATES, LLC | $1.829.560 | 424.000 | 1,47% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.508.282 | 349.544 | 1,21% | Aktien |
| NORTHERN TRUST CORP | $1.482.807 | 343.640 | 1,19% | Aktien |
| UBS Group AG | $1.405.711 | 325.773 | 1,13% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.261.072 | 292.253 | 1,01% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.186.508 | 274.973 | 0,95% | Aktien |
| Knott David M Jr | $1.094.504 | 253.651 | 0,88% | Aktien |
| Flat Footed LLC | $1.084.670 | 251.372 | 0,87% | Aktien |
| Simplify Asset Management Inc. | $946.655 | 219.387 | 0,76% | Aktien |
| GOLDMAN SACHS GROUP INC | $775.000 | 179.606 | 0,62% | Aktien |
| DAFNA Capital Management LLC | $547.319 | 126.841 | 0,44% | Aktien |
| AMH Equity Ltd | $411.680 | 166.000 | 0,33% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $388.350 | 90.000 | 0,31% | Aktien |
| IFP Advisors, Inc | $386.659 | 89.608 | 0,31% | Aktien |
| Daytona Street Capital LLC | $379.336 | 96.398 | 0,31% | Aktien |
| Bank of New York Mellon Corp | $371.534 | 86.103 | 0,30% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $347.789 | 80.600 | 0,28% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $283.944 | 65.804 | 0,23% | Aktien |
| CITADEL ADVISORS LLC | $242.464 | 56.191 | 0,20% | Aktien |
| Nuveen, LLC | $224.889 | 52.118 | 0,18% | Aktien |
| Holos Integrated Wealth LLC | $204.316 | 51.595 | 0,16% | Aktien |
| Cubist Systematic Strategies, LLC | $193.172 | 77.892 | 0,16% | Aktien |
| NewEdge Advisors, LLC | $190.218 | 44.083 | 0,15% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $187.642 | 43.486 | 0,15% | Aktien |
| DEUTSCHE BANK AG\ | $171.383 | 39.672 | 0,14% | Aktien |
| XTX Topco Ltd | $167.482 | 38.814 | 0,13% | Aktien |
| WELLS FARGO & COMPANY/MN | $156.876 | 36.356 | 0,13% | Aktien |
| HighTower Advisors, LLC | $152.643 | 35.375 | 0,12% | Aktien |
| LASRY MARC | $150.955 | 60.869 | 0,12% | Aktien |
| Affinity Asset Advisors, LLC | $144.121 | 33.400 | 0,12% | Aktien |
| RHUMBLINE ADVISERS | $137.813 | 31.940 | 0,11% | Aktien |
| MORGAN STANLEY | $125.826 | 29.160 | 0,10% | Aktien |
| ALGERT GLOBAL LLC | $122.917 | 28.486 | 0,10% | Aktien |
| Meramec Financial Planners, LLC | $114.600 | 30.000 | 0,09% | Aktien |
| TWO SIGMA ADVISERS, LP | $112.465 | 27.100 | 0,09% | Aktien |
| AXQ CAPITAL, LP | $109.808 | 25.448 | 0,09% | Aktien |
| Invesco Ltd. | $106.533 | 24.689 | 0,09% | Aktien |
| MetLife Investment Management, LLC | $103.534 | 23.994 | 0,08% | Aktien |
| BANK OF AMERICA CORP /DE/ | $102.792 | 23.822 | 0,08% | Aktien |
| JPMORGAN CHASE & CO | $99.181 | 20.880 | 0,08% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $97.359 | 22.563 | 0,08% | Aktien |
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| RTW Investments, LP, RTW Master Fund, Ltd., RTW Innovation Master Fund, Ltd., Roderick Wong ×8 Einreichungen | 29. April 2026 | 19,20% | Änderung | · | SEC |
| HSAC 2 Holdings, LLC ×3 Einreichungen | 7. August 2024 | · | Erste Einreichung | · | SEC |
| Geoffrey W. Smith | 7. Februar 2023 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 21 Insider · 11 Führungskräfte · 7 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| David P Hochman | Chief Executive Officer and Chairperson | 10. September 2026 F | 432.916 | 5 | 0 | $149.150 |
| Roderick Wong, M.D. | Chief Executive Officer | 24. Januar 2023 P | 2.808.512 | 0 | 0 | $0 |
| Andrew Lawrence Taylor | Chief Financial Officer | 26. August 2026 F | 589.989 | 0 | 0 | $0 |
| Michael Kaswan | Chief Financial Officer | 26. Januar 2023 A | 162.574 | 0 | 0 | $0 |
| Darren Sherman | President and Chief Operating Officer | 1. Oktober 2026 S | 1.119.402 | 1 | 5 | $-342.290 |
| Joshua Aiello | Principal Accounting Officer | 26. August 2026 F | 18.441 | 0 | 0 | $0 |
| William Reed Little | Executive Vice President, Corporate Development & Strategy | 30. Mai 2024 P | 307.859 | 0 | 0 | $0 |
| George Papandreou | General Manager and Senior Vice President, Focal Therapies | 8. Mai 2024 A | 42.000 | 0 | 0 | $0 |
| Yuval Mika | General Manager and Chief Technology Officer, Bioelectronic Therapies | 8. Mai 2024 A | 158.905 | 0 | 0 | $0 |
| Stephanie A Sirota | VP of Corp Stratege and Comm | 4. August 2020 P | 20.000 | 0 | 0 | $0 |
| Alice Lee | VP Operations, Sec & Treasurer | 4. August 2020 P | 10.000 | 0 | 0 | $0 |
| Connealy Pamela Yanchik | Direktor | 23. Juni 2026 A | 66.038 | 0 | 0 | $0 |
| Jason Aryeh | Direktor | 23. Juni 2026 A | 118.118 | 2 | 0 | $37.481 |
| Eric A Rose MD | Direktor | 20. Juni 2024 A | 7.544 | 0 | 0 | $0 |
| Geoffrey Wade Smith | Direktor | 20. Juli 2023 A | 20.913 | 0 | 0 | $0 |
| HSAC 2 Holdings, LLC | 10%-Eigentümer | 5. August 2024 J | 1.705.705 | 0 | 0 | $0 |
| Medtronic plc | 10%-Eigentümer | 30. Januar 2023 P | 4.999.423 | 0 | 0 | $0 |
| Chris Cleary | · | 12. August 2026 F | 29.153 | 0 | 0 | $0 |
| John Prosper Mack | · | 12. August 2026 F | 66.544 | 0 | 0 | $0 |
| David Pacitti | · | 12. August 2026 F | 54.750 | 0 | 0 | $0 |
| Eric S Fain | · | 12. August 2026 F | 99.630 | 1 | 0 | $82.600 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 10 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,05% | 135.778 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 4.255 SH | 2. Oktober 2026 | Täglich |
| IWO · iShares Trust | 0,02% | 374.286 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 228.058 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 42.916 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 815.602 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 19.057 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 498.632 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.470.063 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.999 SH | 19. August 2026 | Täglich |
OBIO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$11.00
+84,9%
3 23,1%
Starker Kauf
8 61,5%
Kauf
2 15,4%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
7 Analysten · 2026-10-03Mittelwert-Ziel $12.43 +108,9%
← Unter allen Zielen
Aktueller Preis $5.95
Tief$9.00
Mittelwert$12.43
Hoch$20.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| OBIO | $237M | -3.7 | 1169.2% | -157.4% | -195.7% | · |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| SI | $295M | -3.1 | 49.6% | -85.3% | -129.1% | 76.5% |
| CARL | $329M | -5.8 | 85.9% | -58.7% | -375.2% | 75.3% |
| OFIX | $604M | -6.5 | 2.9% | -11.2% | -20.3% | 68.8% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| CV | $501M | -10.4 | 15.3% | -186.8% | 40.3% | 52.9% |
| MOBI | · | · | · | · | · | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 10, 2026